FDA Warning Letter — C. O. Truxton Inc.

Case 535005 — FEI 2220338

The FDA took a Warning Letter action against C. O. Truxton Inc. on Dec 19, 2017 (Bellmawr, NJ). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.

Action details

Facility
C. O. Truxton Inc.
Date
Dec 19, 2017
Fiscal Year
2018
Product Type
Drugs
Center
CDER
Location
Bellmawr, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.